Velorum Therapeutics: Powerful cancer drugs that starve tumors (YC W24)

They build off of p53/SIRT heme regulation pathways...

1. Lidocaine seems to treat many cancers via hemeapoptosis and p53 pathway changes this same way, including ovarian & breast and oral SCC malignancies.

(See: "Lidocaine Promoted Ferroptosis by Targeting miR-382-5p /SLC7A11 Axis in Ovarian and Breast Cancer" (2021) -https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8188239/

and

"Anticancer role of lidocaine in oral squamous cell carcinoma through IGF2BP2-mediated CAV1 stability" (2023) -https://pubmed.ncbi.nlm.nih.gov/38071190/)

===

2. Velorum Therapeutics should explicitly promote p53 pathway more. Many cellular experts still don't implicitly associate p53 (and SIRT + nk-fb) with heme metabolism.